Veradigm | MDRX - Market Capitalization


Veradigm reported $487.8M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 134.3M 53.72M Jun/2025
Ambu A/S DKK 3.14B 21.8B Dec/2025
Amplifon EUR 2.35B 786.16M Mar/2026
Cardinal Health USD 48.83B 11.54B Dec/2025
Centene USD 20.23B 2.7B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Cigna USD 73.52B 3.42B Dec/2025
Coloplast 124.69B 0 Feb/2026
CVS Health USD 100.74B 5.12B Dec/2025
Diasorin EUR 4.23B 858.25M Sep/2025
Elevance Health USD 77.91B 5.15B Dec/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Gulf Medical Proj AED 1.52B 160.75M Mar/2026
Humana USD 30.81B 485M Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Maximus USD 4.7B 307M Dec/2025
McKesson USD 101.25B 5.15B Dec/2025
Med Life RON 4.16B 601.5M Sep/2025
Molina Healthcare USD 8.92B 1.45B Dec/2025
Omnicell USD 2.03B 634M Dec/2025
Oriola-kd EUR 213.12M 18.9M Sep/2025
Owens Minor USD 371M 326M Sep/2025
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Rede D'or Sao Luiz BRL 96.33B 18.17B Sep/2025
Siemens Healthineers EUR 50.67B 1.24B Dec/2025
Supermax Corporation Bhd MYR 1.47B 340.88M Sep/2025
UnitedHealth USD 299.03B 14.21B Dec/2025
Veeva Systems USD 30.4B 3.12B Mar/2026
Veradigm USD 1.69B 34M Sep/2022